Literature DB >> 20868810

Off-pump bilateral versus single skeletonized internal thoracic artery grafting in patients with diabetes.

Takeshi Kinoshita1, Tohru Asai, Osamu Nishimura, Tomoaki Suzuki, Atsushi Kambara, Keiji Matsubayashi.   

Abstract

BACKGROUND: We compared the outcomes in propensity score-matched patients with diabetes undergoing off-pump coronary artery bypass grafting using skeletonized bilateral or single internal thoracic artery (ITA) and assessed any benefit of bilateral ITA grafting for outcomes.
METHODS: Among 770 consecutive patients undergoing isolated coronary artery bypass graft surgery (99.2% by off-pump technique without conversion to cardiopulmonary bypass), 423 patients had diabetes mellitus. After excluding patients who were older than 85 years of age (n = 10) or had only one target vessel at the left coronary area (n = 9), 170 pairs were matched using propensity scores created on the basis of 12 preoperative factors.
RESULTS: Except for 1 patient, bilateral ITA was anastomosed to the left coronary system. Postoperative serum glucose was well controlled in both groups. The rate of deep sternal infection was similar between the groups. The mean observation period was 3.2 years. The 5-year survival free from overall death in bilateral versus single ITA grafting was 87.5% versus 70.8% (log-rank test p = 0.01). For freedom from cardiac death, the respective rate was 92.1% versus 78.7% (p = 0.01). For freedom from cardiac event, the respective rate was 91.0% versus 72.6% (p = 0.01). In multivariate Cox models, bilateral ITA grafting was significantly associated with a lower risk for overall death (hazard ratio, 0.45; 95% confidence interval, 0.22 to 0.89; p = 0.02), cardiac death (hazard ratio, 0.43; 95% confidence interval, 0.21 to 0.87; p = 0.02), and cardiac event (hazard ratio, 0.42; 95% confidence interval, 0.20 to 0.85; p = 0.02).
CONCLUSIONS: Off-pump skeletonized left-sided bilateral ITA grafting is associated with better mid-term outcomes than single ITA grafting, without increasing the risk of deep sternal infection.
Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20868810     DOI: 10.1016/j.athoracsur.2010.05.048

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Bilateral Internal Thoracic Artery Grafting: Is It Reasonable in Octogenarians?

Authors:  Makoto Hashimoto; Toshihiro Fukui; Shuichiro Takanashi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-05-25       Impact factor: 1.520

2.  Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery.

Authors:  Takeshi Kinoshita; Tohru Asai; Tomoaki Suzuki; Atsushi Kambara; Keiji Matsubayashi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 3.  Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Curr Opin Pharmacol       Date:  2012-02-09       Impact factor: 5.547

Review 4.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

5.  Total arterial coronary revascularization-patient selection, stenoses, conduits, targets.

Authors:  James Tatoulis
Journal:  Ann Cardiothorac Surg       Date:  2013-07

6.  Successful introduction of off-pump coronary artery bypass grafting in Southeastern Asian countries: A single center's experience in Thailand.

Authors:  Tomonori Shirasaka; Nuttapon Arayawudhikul; Apichat Tantraworasin; Angsu Chartrungsan; Boonsap Sakboon; Jaroen Cheewinmethasiri; Hiroyuki Kamiya
Journal:  Surg Open Sci       Date:  2022-01-29

Review 7.  Effect of bilateral internal thoracic artery harvesting on deep sternal wound infection in diabetic patients: Review of literature.

Authors:  Matiullah Masroor; Xianming Fu; Umar Zeb Khan; Yuan Zhao
Journal:  Ann Med Surg (Lond)       Date:  2021-05-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.